Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 219-764-3 | CAS number: 2526-62-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Toxicity to reproduction
Administrative data
- Endpoint:
- one-generation reproductive toxicity
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Study period:
- not known
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: The study was carried out in accordance with an appropriate OECD test guideline and in compliance with GLP.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 005
- Report date:
- 2005
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 422 (Combined Repeated Dose Toxicity Study with the Reproduction / Developmental Toxicity Screening Test)
- Qualifier:
- according to guideline
- Guideline:
- other: USEPA OPPTS 870.3650
- GLP compliance:
- yes
- Limit test:
- no
Test material
- Reference substance name:
- 3-(triethoxysilyl)propiononitrile
- EC Number:
- 213-050-5
- EC Name:
- 3-(triethoxysilyl)propiononitrile
- Cas Number:
- 919-31-3
- Molecular formula:
- C9H19NO3Si
- IUPAC Name:
- 3-(triethoxysilyl)propanenitrile
Constituent 1
Test animals
- Species:
- rat
- Strain:
- other: HanBrl:WIST (SPF)
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- Rats were obtained from RCC Ltd Laboratory Animal Services, Fullinsdorf, Switzerland.
Animals were a minimum of 8 weeks of age at delivery. Males were 227-271 grams and females were 165-216 grams. Animals were acclimated for 7 days prior to pairing, under test conditions with an evaluation of the health status. Animals rooms were air conditioned with 10-15 air changes per hour; the environment was monitored continously with recordings of temperature and relative humidity, 12 hours artificial fluorescent light/12 hours dark with background music played at a centrally defined low volume for at least 8 hours during the light period. Animals were housed in Makrolon (R) cages with wire mesh tops and standard granulated softwood bedding. Pelleted standard rat/mouse maintenance diet was available ad libitum. Tap water from Fullinsdorf in bottles was available ad libitum.
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- corn oil
- Details on exposure:
- The test item was adminsitered once daily, by gavage. All animals received a dose volume of 2 ml/kg body weight with a daily adjustment of the individual volume to the actual body weight. Control animals were dosed with the vehicle alone.
- Details on mating procedure:
- Females were paired with males (1:1) from the same treatment group until evidence of mating was obtained (vaginal plug or
sperm-positive vaginal smear). Length of cohabitation did not exceed 14 days. - Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- Samples for determination of actual test item concentrations, stability (7 day) and homogeneity in the prepared mixtures were taken on the first day of preparation. Samples for determination of actual test item concentrations and homogeneity were also taken on one occasion during the gestation period. Analysis were performed using a Gas Chromatographic method.
- Duration of treatment / exposure:
- Exposure period: Premating (14 days), mating, gestation, and postpartum days 1-3 for a maximum total of 44 days depending on
duration of mating phase.
Premating exposure period (males): 14 days
Premating exposure period (females): 14 days
Duration of test: up to a maximum of 44 days - Frequency of treatment:
- daily
- Details on study schedule:
- Animals of both sexes received test article for 14 days prior to pairing and during pairing period. Daily dosing of the females was continued
throughout pregnancy and up to day 3 of lactation. Males were dosed for a minimum of 28 days.
Doses / concentrations
- Remarks:
- Doses / Concentrations:
100, 500, and 1000 mg/kg bw/day
Basis:
- No. of animals per sex per dose:
- 10/sex/group
- Control animals:
- yes, concurrent vehicle
- Details on study design:
- 3-(triethoxysilyl)propiononitrile was administered once daily orally (by gavage) to 10 males and 20 female (10 toxicity group and 10 reproductive group females) rats at doses of 100, 500 and 1000 mg/kg bw/day. A concurrent vehicle control group (dried corn oil) was also included. Males and toxicity group females were sacrificed after they had been treated for at least 28 days; reproductive group females were dosed throughout the
preparing (14 day), pairing and gestation periods until day 3 of lactation up to a maximum of 44 days; reproductive group females and
pups were sacrificed on day 4 of lactation.
Details on mating: After a pre-paring period of 14 days, males and females in the Reproductive groups were paired overnight, in the ratio of 1 male to 1 female. The female was placed with the same male until mating occured or two weeks had elapsed. The day on which spermatozoa was observed was designated day 0 post coitum. After mating was ascertained, the animals were separated and housed individually. The females were allowed to litter and rear their progeny to day 4 of lactation.
Examinations
- Parental animals: Observations and examinations:
- Parameters assessed during study (maternal and fetal):
Maternal body weight, food consumption, and clinical observations.
Clinical observations performed and frequency: General clinical observations were made twice daily to assess external condition, behavior and
mortality/morbidity. Detailed clinical observations were conducted weekly and were performed after the exposure period. Examinations
included assessment of external condition, behavior, autonomic activity, gait and posture. Additionally, the females were observed for
signs of difficult or prolonged parturition. The dams were observed daily for survival and behavioral abnormalities in nesting. - Litter observations:
- Live birth, stillbirth, any gross abnormalities and weight, litter weight gain, and macroscopic observations were noted.
- Postmortem examinations (parental animals):
- Organs examined at necropsy (macroscopic and microscopic): The number of implantation sites and corpora lutea were determined at necropsy.
- Postmortem examinations (offspring):
- Live birth, stillbirth, any gross abnormalities and weight, litter weight gain, and macroscopic observations were noted.
- Statistics:
- Statistical methods: Mean and standard deviations of data of various parameters were calculated. Univariate one-way analysis of variance
was used to assess the significance of intergroup differences. Dunnett t-test, based on a pooled variance estimate, was used for intergroup
comparisons. The Steel test (rank test) was applied when the data could not be assumed to follow a normal distribution. Fisher's Exact test
for 2x2 tables was applied if the variables could be dichotomized without loss of information. Statistically significant probabilities are
reported at either the p<0.05 or p<0.01 levels. - Reproductive indices:
- Gonadal function, mating behavior, conception, development of the conceptus and parturition
Results and discussion
Results: P0 (first parental generation)
General toxicity (P0)
- Clinical signs:
- no effects observed
- Dermal irritation (if dermal study):
- not examined
- Mortality:
- not specified
- Body weight and weight changes:
- no effects observed
- Food consumption and compound intake (if feeding study):
- no effects observed
- Food efficiency:
- not specified
- Water consumption and compound intake (if drinking water study):
- not examined
- Ophthalmological findings:
- not specified
- Haematological findings:
- not specified
- Clinical biochemistry findings:
- not specified
- Urinalysis findings:
- not specified
- Behaviour (functional findings):
- not specified
- Immunological findings:
- not examined
- Organ weight findings including organ / body weight ratios:
- not examined
- Histopathological findings: non-neoplastic:
- not examined
- Histopathological findings: neoplastic:
- not specified
- Other effects:
- not specified
Reproductive function / performance (P0)
- Reproductive function: oestrous cycle:
- no effects observed
- Reproductive function: sperm measures:
- no effects observed
- Reproductive performance:
- no effects observed
Details on results (P0)
No abnormal findings were noted in any treated groups for 4 days post-partum. No treatment-related effects were observed in any of the reproductive parameters evaluated. All females produced litters that were similar in all respects to control litters.
" Mortality and day of death: None.
" Number pregnant per dose level: 10, 10, 10 and 9 for 0,100, 500 and 1000 mg/kg bw/day
" Number aborting: 0 "
" Number of resorptions, early/late if available: Not reported.
" Number of implantations: Group Mean (standard deviation): Control: 13.7 (1.34); 100 mg/kg: 13.5 (3.10); 500 mg/kg: 14.2 (2.15); 1000 mg/kg: 13.6 (2.51)
" Pre and post implantation loss, if available: Post implantation loss: Control: 1.4 (1.43); 100 mg/kg: 1.4 (1.58); 500mg/kg: 0.7 (1.06); 1000 mg/kg: 1.7 (1.58)
" Number of corpora lutea: Group Mean (standard deviation): Control: 24.1 (5.0); 100 mg/kg: 23.5 (4.4); 500 mg/kg: 23.5(3.1); 1000 mg/kg: 24.7 (3.8)
" Duration of Pregnancy: Group Mean (standard deviation): Control: 21.6 (0.52); 100 mg/kg: 21.6 (0.52); 500 mg/kg: 21.7 (0.48); 1000 mg/kg: 21.7 (0.50)
" Body weight: No statistically significant differences in treatment group maternal body weight relative to control group animals.
" Food/water consumption: No statistically significant differences in treatment group maternal food consumption relative to control
group animals.
" Description, severity, time of onset and duration of clinical signs: Commencing around day 14 of gestation and for the duration of
the remaining treatment period, all females of the high dose group showed signs of discomfort after administration of the test article
(pushing head through bedding material). During this period, stretched forelimbs were noted on single or few days in six females. For
four females, saltatory spasms were noted for up to few days.
" Gross pathology incidence and severity: Gross pathology of the reproductive/developmental group animals was not an endpoint
for this study.
" Organ weight changes, particularly effects on total uterine weight: Organ weight was not assessed in the reproductive/developmental
group animals.
" Histopathology incidence and severity: Histopathology was not assessed in the reproductive/developmental group animals.
Effect levels (P0)
- Dose descriptor:
- NOAEL
- Effect level:
- 1 000 mg/kg bw/day
- Sex:
- male/female
Results: F1 generation
General toxicity (F1)
- Clinical signs:
- no effects observed
- Dermal irritation (if dermal study):
- not examined
- Mortality / viability:
- no mortality observed
- Body weight and weight changes:
- no effects observed
- Food consumption and compound intake (if feeding study):
- not specified
- Food efficiency:
- not specified
- Water consumption and compound intake (if drinking water study):
- not examined
- Ophthalmological findings:
- not specified
- Haematological findings:
- not specified
- Clinical biochemistry findings:
- not specified
- Urinalysis findings:
- not specified
- Sexual maturation:
- not examined
- Organ weight findings including organ / body weight ratios:
- not examined
- Gross pathological findings:
- no effects observed
- Histopathological findings:
- not examined
- Other effects:
- not specified
Developmental neurotoxicity (F1)
- Behaviour (functional findings):
- not specified
Developmental immunotoxicity (F1)
- Developmental immunotoxicity:
- not examined
Details on results (F1)
Effect levels (F1)
- Dose descriptor:
- NOAEL
- Generation:
- F1
- Effect level:
- 1 000 mg/kg bw/day
- Sex:
- male/female
Overall reproductive toxicity
- Reproductive effects observed:
- not specified
Applicant's summary and conclusion
- Conclusions:
- No treatment-related effects were observed in any of the
reproductive parameters evaluated. Based on the results of
this screening study,
the NOAEL for maternal and reproductive toxicity of 3-(triethoxysilyl)propiononitrile in the rat via oral dosing was determined to be 1000
mg/kg bw/day.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.